Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2010 2
2011 2
2012 2
2013 2
2014 2
2015 2
2016 1
2017 4
2018 2
2019 2
2020 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents.
Hagemans IM, Wierstra PJ, Steuten K, Molkenboer-Kuenen JDM, van Dalen D, Ter Beest M, van der Schoot JMS, Ilina O, Gotthardt M, Figdor CG, Scheeren FA, Heskamp S, Verdoes M. Hagemans IM, et al. Among authors: molkenboer kuenen jdm. J Nanobiotechnology. 2022 Feb 2;20(1):64. doi: 10.1186/s12951-022-01272-5. J Nanobiotechnology. 2022. PMID: 35109860 Free PMC article.
Correction to: Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents Iris.
Hagemans IM, Wierstra PJ, Steuten K, Molkenboer-Kuenen JDM, van Dalen D, Ter Beest M, van der Schoot JMS, Ilina O, Gotthardt M, Figdor CG, Scheeren FA, Heskamp S, Verdoes M. Hagemans IM, et al. Among authors: molkenboer kuenen jdm. J Nanobiotechnology. 2022 May 14;20(1):229. doi: 10.1186/s12951-022-01306-y. J Nanobiotechnology. 2022. PMID: 35568872 Free PMC article. No abstract available.
Dynamics of IGF-1R expression during endocrine breast cancer treatment.
Heskamp S, Boerman OC, Molkenboer-Kuenen JD, Koornstra RH, Linn SC, Oyen WJ, van der Graaf WT, van Laarhoven HW. Heskamp S, et al. Among authors: molkenboer kuenen jd. Mol Imaging Biol. 2014 Aug;16(4):529-37. doi: 10.1007/s11307-014-0723-6. Mol Imaging Biol. 2014. PMID: 24532107
Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [68Ga]Ga-DOTA-E-[c(RGDfK)]2 PET/CT.
Lobeek D, Rijpkema M, Terry SYA, Molkenboer-Kuenen JDM, Joosten L, van Genugten EAJ, van Engen-van Grunsven ACH, Kaanders JHAM, Pegge SAH, Boerman OC, Weijs WLJ, Merkx MAW, van Herpen CML, Takes RP, Aarntzen EHJG, Oyen WJG. Lobeek D, et al. Among authors: molkenboer kuenen jdm. Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2647-2655. doi: 10.1007/s00259-020-04766-2. Epub 2020 Mar 20. Eur J Nucl Med Mol Imaging. 2020. PMID: 32198613 Free PMC article.
213Bi-Labeled Prostate-Specific Membrane Antigen-Targeting Agents Induce DNA Double-Strand Breaks in Prostate Cancer Xenografts.
Nonnekens J, Chatalic KL, Molkenboer-Kuenen JD, Beerens CE, Bruchertseifer F, Morgenstern A, Veldhoven-Zweistra J, Schottelius M, Wester HJ, van Gent DC, van Weerden WM, Boerman OC, de Jong M, Heskamp S. Nonnekens J, et al. Among authors: molkenboer kuenen jd. Cancer Biother Radiopharm. 2017 Mar;32(2):67-73. doi: 10.1089/cbr.2016.2155. Cancer Biother Radiopharm. 2017. PMID: 28301262
α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.
Heskamp S, Hernandez R, Molkenboer-Kuenen JDM, Essler M, Bruchertseifer F, Morgenstern A, Steenbergen EJ, Cai W, Seidl C, McBride WJ, Goldenberg DM, Boerman OC. Heskamp S, et al. Among authors: molkenboer kuenen jdm. J Nucl Med. 2017 Jun;58(6):926-933. doi: 10.2967/jnumed.116.187021. Epub 2017 Feb 23. J Nucl Med. 2017. PMID: 28232604 Free PMC article.
A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using 68Ga-RGD PET/CT.
Lobeek D, Bouwman FCM, Aarntzen EHJG, Molkenboer-Kuenen JDM, Flucke UE, Nguyen HL, Vikkula M, Boon LM, Klein W, Laverman P, Oyen WJG, Boerman OC, Terry SYA, Schultze Kool LJ, Rijpkema M. Lobeek D, et al. Among authors: molkenboer kuenen jdm. J Nucl Med. 2020 Feb;61(2):270-275. doi: 10.2967/jnumed.119.231167. Epub 2019 Sep 13. J Nucl Med. 2020. PMID: 31519800 Free PMC article. Clinical Trial.
PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer.
Heskamp S, Wierstra PJ, Molkenboer-Kuenen JDM, Sandker GW, Thordardottir S, Cany J, Olive D, Bussink J, Boerman OC, Dolstra H, Aarntzen EHJG, Hobo WA. Heskamp S, et al. Among authors: molkenboer kuenen jdm. Cancer Immunol Res. 2019 Jan;7(1):150-161. doi: 10.1158/2326-6066.CIR-18-0280. Epub 2018 Nov 20. Cancer Immunol Res. 2019. PMID: 30459153
23 results